Moreover, the same compound is able to inhibit the generation and accumulation of MDSCs in the tumour and metastasis sites in different mouse models via reduction of c/EBPβ expression and in turn levels of G-CSF, one of the factors responsible for MDSC recruitment to the TME [179]. The gene discussed is CSF3; the disease is neoplasm.